Catastrophic Antiphospholipid Syndrome in Obstetric Practice
- Authors: Makatsariya A.D1, Bitsadze V.O2, Khizroeva D.K.2
-
Affiliations:
- First Moscow State Medical University
- I. M. Sechenov First Moscow State Medical University
- Issue: Vol 61, No 3 (2012)
- Pages: 7-21
- Section: Current public health problems
- URL: https://journals.rcsi.science/jowd/article/view/1281
- DOI: https://doi.org/10.17816/JOWD6137-21
- ID: 1281
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Alexander D Makatsariya
First Moscow State Medical University
Email: gemostasis@mail.ru
MD, PhD Professor, Correspondent Member of the RAMS, Head of the Chair of Obstetrics and Gynecology of Medical Prophylaxis Faculty, Vice-President of Russian Association of Obstetricians and Gynaecologists
Viktoriya O Bitsadze
I. M. Sechenov First Moscow State Medical University
Email: gemostasis@mail.ru
MD, PhD Professor of the Chair of Obstetrics and Gynecology of Medical Prophylaxis Faculty
Dzhamilya Kh Khizroeva
I. M. Sechenov First Moscow State Medical University
Email: gemostasis@mail.ru
MD, PhD, assistant of the Chair of Obstetrics and Gynecology of Medical Prophylaxis Faculty
References
- Антифосфолипидный синдром — иммунная тромбофилия в акушерстве и гинекологии / Макацария А. Д. [и др.]. — М.: Триада-Х, 2007. — 456 с.
- Баркаган З. С., Момот А. П., Сердюк Г. В. Основы диагностики и терапии антифосфолипидного синдрома. — М.: Ньюдиамед, 2003. — 48 с.
- Долгушина Н. В., Макацария А. Д. Вирусные инфекции у беременных: руководство для врачей. — М.:Триада-Х, 2004. — 144 с.
- Насонов Е. Л. Антифосфолипидный синдром. — М.: Литера, 2004. — 440 с.
- Насонов Е. Л. Современные подходы к профилактике и лечению антифосфолипидного синдрома // Терапевтический архив. — 2003. — № 5. — С. 83–87.
- Хизроева Д. Х. Антифосфолипидные антитела и тромботический шторм // Материалы XIII Всероссийского научного форума «Мать и Дитя». — М., 2011. — С. 213–214.
- Acute respiratory failure associated with catastrophic antiphospholipid syndrome / Wiedermann F. J. [et al.] // J. Intern. Med. — 2000. — Vol. 247. — P. 723–730.
- Asherson R. A. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome // Immunobiology. — 2005. — Vol. 210. — P. 727–733.
- Asherson R. A. The catastrophic antiphospholipid syndrome // J. Rheumatol. — 1992. — Vol. 19. — P. 508–512.
- Asherson R. A., Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome — molecular mimicry? // J. Rheumatol. — 2000. — Vol. 27. — P. 12–14.
- Bashiri A., Burstein E., Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review // J. Perinat. Med. — 2006. — Vol. 34, N 1. — P. 5–12.
- Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome / Cervera R. [et al.] // Ann. Rheum. Dis. — 2005. — Vol. 64. — P. 1205–1209.
- Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines / Asherson R. A. [et al.] // Lupus. — 2003. — Vol. 12. — P. 530–534.
- Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis // Crit. Care Med. — 2000. — Vol. 28. — P. 9–11.
- Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients / Asherson R. A. [et al.] // Ann. Rheum. Dis. — 2005. — Vol. 64. — P. 943–946.
- Fetal thrombophilia and obstetrics complications / Makatsariya A. [et al.] // Pathophysiology of haemostasis and thrombosis: proceeding and abstracts from the 19th International Congress on Thrombosis. — Tel-Aviv, Israel, 2006. — P. A10.
- Gharavi A. E., Pierangeli S. S., Harris E. N. New developments in viral peptides and APL induction // J. Autoimmun. — 2000. — Vol. 15. — P. 227–230.
- Groot de P. G., Horbach D. A., Derksen R. H. Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis // Lupus. — 1996. — Vol. 5. — P. 488–493.
- Haemotology. Clinical cases uncovered / Shaun McCann [et al.]. — N-Y.: Wiley-Blackwell. A John Wiley & Sons, Ltd., 2009. — 190 p.
- Hemostasis and Thrombosis in obstetrics and gynecology / M. J. Paidas [et al.]. — Lockwood: Willey-Blackwell, 2011. — 223 p.
- High prevalence of antiphospholipid antibodies in disseminated intravascular coagulation / Karmochkine M. [et al.] // Thromb. Haemost. — 1996. — Vol. 75. — P. 971.
- Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome / Lu C. S. [et al.] // Arthritis Rheum. — 2005. — Vol. 52. — P. 4018–4027.
- Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications / Carmona F. [et al.] // Am. J. Obstet. Gynecol. — 2006. — Vol. 194. — P. 457–465.
- Induction of antiphospholipid syndrome in Factor V Leiden mice / Katzav A. [et al.] // Immunobiology. — 2005. — Vol. 209. — P. 10–11.
- Kitchens C. S. Thrombotic storm: when thrombosis begets thrombosis // Am. J. Med. — 1998. — Vol. 104. — P. 381–385.
- Lai S., Walker D. H., Elghetany M. T. Catastrophic antiphospholipid syndrome: a rare cause of disseminated microvascular thrombotic injury — a case report with pathological and molecular correlative studies // Pathol. Int. — 2005. — Vol. 55. — P. 144–149.
- LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study / Brenner B. [et al.] // J. Thromb. Haemost. — 2005. — Vol.3. — P. 227–229.
- Makatsariya A., Asherson R. A., Bitsadze V. Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics / [et al.] // Autoimmun Rev. — 2006. — Vol. 6, N 2. — P. 89–93.
- Nelson S. M., Greer I. A. The potential role of heparin in assisted conception // Human Reproduction Update. — 2008. — Vol. 14, N 6. — P. 623–645.
- Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations / Erkan D. [et al.] // J. Rheumatol. — 2002. — Vol. 29, N 4. — P. 843–849.
- Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombine ant human activated protein C for severe sepsis / Bernard G. R. [et al.] // N. Engl. J. Med. — 2001. — Vol. 344, N 10. — P. 699–709.
- Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies / Raschi E. [et al.] // Blood. — 2003. — Vol. 101. — P. 3495–3500.
- Shoenfeld Y. The infectious etiology of APS: Novel cross reactive epitopes on yeasts, bacteria and viruses // Immunobiology. — 2005. — Vol. 209, suppl. 1.
- Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant / Yasuda S. [et al.] // Arthritis Rheum. — 2005. — Vol. 52, N 1. — P. 212–218.
- The Catastrophic Antiphospholipid Syndrome (Asherson's Syndrome). — N-Y.: Monograph. Collected papers, 2005. — 112 p.
- The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women / Le Thi Thuong D. [et al.] // Ann. Rheum. Dis. — 2005. — Vol. 64. — P. 273–278.
- Vora S. K., Asherson R. A., Erkan D. Catastrophic antiphospholipid syndrome // J. Intensive. Care Med. — 2006. — Vol. 21. — P. 144–159.